Selected research
Industry Growth & Trends
Global Cinnarizine Industry Growth and Trends Forecast to 2032
Market perspective
The global Cinnarizine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Cinnarizine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Cinnarizine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cinnarizine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cinnarizine include Teva, Johnson And Johnson, Novartis, Mylan, Zambon, Sopharma, Nidda Healthcare, March Pharma and Leti Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Cinnarizine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Cinnarizine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cinnarizine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cinnarizine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Cinnarizine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Cinnarizine Market by Company
Teva
Johnson And Johnson
Novartis
Mylan
Zambon
Sopharma
Nidda Healthcare
March Pharma
Leti Pharma
Inga Laboratories
Hasco-Lek
Goodwill Pharma
Gedeon Richter
Eurogenerics
Aurobindo Pharma
Apotex
Allena Pharmaceuticals
Cinnarizine Segment by Type
On-line
Drug Store
Hospital
Cinnarizine Segment by Application
Histamine H₁-Receptor Antagonist
Antiemetic Agent
Antivertigo Agent
Cinnarizine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cinnarizine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cinnarizine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cinnarizine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cinnarizine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Cinnarizine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- On-line
- Drug Store
- Hospital
Applications
- Histamine H₁-Receptor Antagonist
- Antiemetic Agent
- Antivertigo Agent
Companies covered
- Teva
- Johnson And Johnson
- Novartis
- Mylan
- Zambon
- Sopharma
- Nidda Healthcare
- March Pharma
- Leti Pharma
- Inga Laboratories
- Hasco-Lek
- Goodwill Pharma
- Gedeon Richter
- Eurogenerics
- Aurobindo Pharma
- Apotex
- Allena Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Cinnarizine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Cinnarizine Sales Estimates and Forecasts (2021-2032)
- 1.3 Cinnarizine Market by Type
- 1.3.1 On-line
- 1.3.2 Drug Store
- 1.3.3 Hospital
- 1.4 Global Cinnarizine Market Size by Type
- 1.4.1 Global Cinnarizine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Cinnarizine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Cinnarizine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Cinnarizine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Cinnarizine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Cinnarizine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Cinnarizine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Cinnarizine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Cinnarizine Industry Trends
- 2.2 Cinnarizine Industry Drivers
- 2.3 Cinnarizine Industry Opportunities and Challenges
- 2.4 Cinnarizine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Cinnarizine Revenue (2021-2026)
- 3.2 Global Top Players by Cinnarizine Sales (2021-2026)
- 3.3 Global Top Players by Cinnarizine Price (2021-2026)
- 3.4 Global Cinnarizine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cinnarizine Major Company Production Sites & Headquarters
- 3.6 Global Cinnarizine Company, Product Type & Application
- 3.7 Global Cinnarizine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cinnarizine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cinnarizine Players Market Share by Revenue in 2025
- 3.8.3 2025 Cinnarizine Tier 1, Tier 2, and Tier 3
4 Cinnarizine Regional Status and Outlook
- 4.1 Global Cinnarizine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Cinnarizine Historic Market Size by Region
- 4.2.1 Global Cinnarizine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Cinnarizine Sales in Value by Region (2021-2026)
- 4.2.3 Global Cinnarizine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Cinnarizine Forecasted Market Size by Region
- 4.3.1 Global Cinnarizine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Cinnarizine Sales in Value by Region (2027-2032)
- 4.3.3 Global Cinnarizine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cinnarizine by Application
- 5.1 Cinnarizine Market by Application
- 5.1.1 Histamine H₁-Receptor Antagonist
- 5.1.2 Antiemetic Agent
- 5.1.3 Antivertigo Agent
- 5.2 Global Cinnarizine Market Size by Application
- 5.2.1 Global Cinnarizine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Cinnarizine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Cinnarizine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Cinnarizine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Cinnarizine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Cinnarizine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Cinnarizine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Cinnarizine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva
- 6.1.1 Teva Company Information
- 6.1.2 Teva Business Overview
- 6.1.3 Teva Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva Cinnarizine Product Portfolio
- 6.1.5 Teva Recent Developments
- 6.2 Johnson And Johnson
- 6.2.1 Johnson And Johnson Company Information
- 6.2.2 Johnson And Johnson Business Overview
- 6.2.3 Johnson And Johnson Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Johnson And Johnson Cinnarizine Product Portfolio
- 6.2.5 Johnson And Johnson Recent Developments
- 6.3 Novartis
- 6.3.1 Novartis Company Information
- 6.3.2 Novartis Business Overview
- 6.3.3 Novartis Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Novartis Cinnarizine Product Portfolio
- 6.3.5 Novartis Recent Developments
- 6.4 Mylan
- 6.4.1 Mylan Company Information
- 6.4.2 Mylan Business Overview
- 6.4.3 Mylan Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Mylan Cinnarizine Product Portfolio
- 6.4.5 Mylan Recent Developments
- 6.5 Zambon
- 6.5.1 Zambon Company Information
- 6.5.2 Zambon Business Overview
- 6.5.3 Zambon Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Zambon Cinnarizine Product Portfolio
- 6.5.5 Zambon Recent Developments
- 6.6 Sopharma
- 6.6.1 Sopharma Company Information
- 6.6.2 Sopharma Business Overview
- 6.6.3 Sopharma Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Sopharma Cinnarizine Product Portfolio
- 6.6.5 Sopharma Recent Developments
- 6.7 Nidda Healthcare
- 6.7.1 Nidda Healthcare Company Information
- 6.7.2 Nidda Healthcare Business Overview
- 6.7.3 Nidda Healthcare Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Nidda Healthcare Cinnarizine Product Portfolio
- 6.7.5 Nidda Healthcare Recent Developments
- 6.8 March Pharma
- 6.8.1 March Pharma Company Information
- 6.8.2 March Pharma Business Overview
- 6.8.3 March Pharma Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 March Pharma Cinnarizine Product Portfolio
- 6.8.5 March Pharma Recent Developments
- 6.9 Leti Pharma
- 6.9.1 Leti Pharma Company Information
- 6.9.2 Leti Pharma Business Overview
- 6.9.3 Leti Pharma Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Leti Pharma Cinnarizine Product Portfolio
- 6.9.5 Leti Pharma Recent Developments
- 6.10 Inga Laboratories
- 6.10.1 Inga Laboratories Company Information
- 6.10.2 Inga Laboratories Business Overview
- 6.10.3 Inga Laboratories Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Inga Laboratories Cinnarizine Product Portfolio
- 6.10.5 Inga Laboratories Recent Developments
- 6.11 Hasco-Lek
- 6.11.1 Hasco-Lek Company Information
- 6.11.2 Hasco-Lek Business Overview
- 6.11.3 Hasco-Lek Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Hasco-Lek Cinnarizine Product Portfolio
- 6.11.5 Hasco-Lek Recent Developments
- 6.12 Goodwill Pharma
- 6.12.1 Goodwill Pharma Company Information
- 6.12.2 Goodwill Pharma Business Overview
- 6.12.3 Goodwill Pharma Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Goodwill Pharma Cinnarizine Product Portfolio
- 6.12.5 Goodwill Pharma Recent Developments
- 6.13 Gedeon Richter
- 6.13.1 Gedeon Richter Company Information
- 6.13.2 Gedeon Richter Business Overview
- 6.13.3 Gedeon Richter Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Gedeon Richter Cinnarizine Product Portfolio
- 6.13.5 Gedeon Richter Recent Developments
- 6.14 Eurogenerics
- 6.14.1 Eurogenerics Company Information
- 6.14.2 Eurogenerics Business Overview
- 6.14.3 Eurogenerics Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Eurogenerics Cinnarizine Product Portfolio
- 6.14.5 Eurogenerics Recent Developments
- 6.15 Aurobindo Pharma
- 6.15.1 Aurobindo Pharma Company Information
- 6.15.2 Aurobindo Pharma Business Overview
- 6.15.3 Aurobindo Pharma Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Aurobindo Pharma Cinnarizine Product Portfolio
- 6.15.5 Aurobindo Pharma Recent Developments
- 6.16 Apotex
- 6.16.1 Apotex Company Information
- 6.16.2 Apotex Business Overview
- 6.16.3 Apotex Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Apotex Cinnarizine Product Portfolio
- 6.16.5 Apotex Recent Developments
- 6.17 Allena Pharmaceuticals
- 6.17.1 Allena Pharmaceuticals Company Information
- 6.17.2 Allena Pharmaceuticals Business Overview
- 6.17.3 Allena Pharmaceuticals Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Allena Pharmaceuticals Cinnarizine Product Portfolio
- 6.17.5 Allena Pharmaceuticals Recent Developments
7 North America by Country
- 7.1 North America Cinnarizine Sales by Country
- 7.1.1 North America Cinnarizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Cinnarizine Sales by Country (2021-2026)
- 7.1.3 North America Cinnarizine Sales Forecast by Country (2027-2032)
- 7.2 North America Cinnarizine Market Size by Country
- 7.2.1 North America Cinnarizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Cinnarizine Market Size by Country (2021-2026)
- 7.2.3 North America Cinnarizine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Cinnarizine Sales by Country
- 8.1.1 Europe Cinnarizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Cinnarizine Sales by Country (2021-2026)
- 8.1.3 Europe Cinnarizine Sales Forecast by Country (2027-2032)
- 8.2 Europe Cinnarizine Market Size by Country
- 8.2.1 Europe Cinnarizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Cinnarizine Market Size by Country (2021-2026)
- 8.2.3 Europe Cinnarizine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Cinnarizine Sales by Country
- 9.1.1 Asia-Pacific Cinnarizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Cinnarizine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Cinnarizine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Cinnarizine Market Size by Country
- 9.2.1 Asia-Pacific Cinnarizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Cinnarizine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Cinnarizine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Cinnarizine Sales by Country
- 10.1.1 South America Cinnarizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Cinnarizine Sales by Country (2021-2026)
- 10.1.3 South America Cinnarizine Sales Forecast by Country (2027-2032)
- 10.2 South America Cinnarizine Market Size by Country
- 10.2.1 South America Cinnarizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Cinnarizine Market Size by Country (2021-2026)
- 10.2.3 South America Cinnarizine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Cinnarizine Sales by Country
- 11.1.1 Middle East and Africa Cinnarizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Cinnarizine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Cinnarizine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Cinnarizine Market Size by Country
- 11.2.1 Middle East and Africa Cinnarizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Cinnarizine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Cinnarizine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Cinnarizine Value Chain Analysis
- 12.1.1 Cinnarizine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Cinnarizine Production Mode & Process
- 12.2 Cinnarizine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Cinnarizine Distributors
- 12.2.3 Cinnarizine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst